002422SZSE

Announcement on the Progress of Share Buyback by Sichuan Kelun Pharmaceutical Co., Ltd.

✨ AI Summary

Sichuan Kelun Pharmaceutical Co., Ltd. has announced the progress of its share buyback plan, approved by the board on January 4, 2026. The buyback price has been adjusted to a maximum of 34.53 RMB per share, effective May 11, 2026. As of May 31, 2026, the company has repurchased 350,000 shares, representing 0.02% of its total share capital, for a total amount of 10,366,040 RMB.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Announcement on the Progress of Share Buyback by Sichuan Kelun Pharmaceutical Co., Ltd.

The company and all members of the board guarantee that the content of this information disclosure is true, accurate, and complete, without any false records, misleading statements, or significant omissions.

Sichuan Kelun Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") has had the proposal regarding the share buyback plan reviewed and approved at the 11th meeting of the 8th Board of Directors held on January 4, 2026. The Company disclosed the "Resolution Announcement of the 11th Meeting of the 8th Board of Directors" and the "Announcement on the Share Buyback Plan and Buyback Report" on January 6, 2026, on the designated information disclosure website, www.cninfo.com.cn, as well as in the Securities Times, Shanghai Securities Journal, Securities Daily, and China Securities Journal.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.